Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development
2022-01-07 08:30
Pudu Robotics' New Afra C1 Cleaning Robot Makes its Global Debut at CES 2022
2022-01-07 00:00
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases
2022-01-06 22:00
Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021
2022-01-06 21:00
I-Mab Announces Senior Management Team Share Purchase Plan
2022-01-06 21:00
Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's
2022-01-06 20:30
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
2022-01-06 19:00
Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines
2022-01-06 14:45
Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference
2022-01-06 08:30
Adlai Nortye Announces First Patient Dosed in Phase I Clinical Trial of the orally available, small-molecule PD-L1 inhibitor AN4005 for Advanced Tumors
2022-01-06 01:00
Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes
2022-01-05 22:00
ITRI Introduces Health Tech Innovations at CES 2022
2022-01-05 21:00
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
2022-01-05 20:45
Coway Unveils New Smart Home Solutions at CES 2022
2022-01-05 13:02
Accro Bioscience inks over $50M series B round
2022-01-05 11:08
PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech
2022-01-05 09:00
BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics
2022-01-05 08:07
Hutech Massage Chair First Unveiling of "Sonic Wave Car Seat" at CES 2022, Strengthening global presence
2022-01-04 21:00
Zepp Health To Host Wearables Data in Healthcare State-of-the-Union Event with Industry Thought Leaders on January 5, 2022
2022-01-04 20:00
Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003
2022-01-04 17:28
1
144
145
146
147
148
766